Investor Suit Over Savient Gout Drug Reactions Fails
A federal judge has dismissed an investor lawsuit alleging Savient Pharmaceuticals Inc. held back reports of adverse reactions to its gout drug pegloticase in an effort to get backing from a...To view the full article, register now.
Already a subscriber? Click here to view full article